VAERS Explorer
Back to explore

Report #2861227

Received Sep 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
1.3 yrs
State
FL
Recovered
Unknown
Vaccinated
Sep 5, 2025
Onset
Sep 5, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
DTAPIPVHIBDTAP + IPV + HIB (PENTACEL)SANOFI PASTEURUNKUK226AAOT / LL

Symptoms (2)

No adverse eventProduct preparation issue

Symptom narrative

gave PENTACEL, but they only gave the diluent and not the vaccine with no reported AE; Initial information received on 19-Sep-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 15 months old male patient who was administered Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] but they only gave the diluent and not the vaccine with no reported ae (adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria Vaccine Toxoid, Hepatitis B Vaccine Rhbsag (Yeast), Hib Vaccine Conj (Menigococcal Protein), Pertussis Vaccine Acellular 5-Component, Polio Vaccine Inact 3v (Vero), Tetanus Vaccine Toxoid (Vaxelis) for Immunisation; And Pneumococcal Vaccine Conj 20v (Crm197) (Prevnar 20) for Immunisation. On 05-Sep-2025, the patient received an unknown dose of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] Suspension for injection (lot UK226AA and expiry date-Aug-2026) via intramuscular route in the left thigh for TB skin test (Skin test) where the patient was only given the diluent and not the vaccine with no reported ae (single component of a two-component product) frequency-once, standard strength, (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Other medications

VAXELIS; PREVNAR 20